PT - JOURNAL ARTICLE AU - Vinueza Veloz, María Fernanda AU - Bhatta, Laxmi AU - Jones, Paul Remy AU - Tesli, Martin AU - Smith, George Davey AU - Davies, Neil Martin AU - Brumpton, Ben M. AU - Næss, Øyvind Erik TI - Educational attainment and mental health conditions: a within-sibship Mendelian randomization study AID - 10.1101/2024.08.10.24311789 DP - 2024 Jan 01 TA - medRxiv PG - 2024.08.10.24311789 4099 - http://medrxiv.org/content/early/2024/08/11/2024.08.10.24311789.short 4100 - http://medrxiv.org/content/early/2024/08/11/2024.08.10.24311789.full AB - Importance Observational studies have demonstrated consistent protective effects of higher educational attainment (EA) on the risk of suffering mental health conditions (MHC). Determining whether these beneficial effects are causal is challenging given the potential role of dynastic effects and demographic factors (assortative mating and population structure) in this association.Objective To evaluate to what extent the relationship between EA and various MHC is independent from dynastic effects and demographic factors.Design Within-sibship Mendelian randomization (MR) study.Setting One-sample MR analyses included participants’ data from the Trøndelag Health Study (HUNT, Norway) and UK Biobank (United Kingdom). For two-sample MR analyses we used summary statistics from publicly available genome-wide-association-studies.Participants 61 880 siblings (27 507 sibships).Exposure Years of education.Main outcomes Scores for symptoms of anxiety, depression and neuroticism using the Hospital Anxiety Depression Scale (HADS), the 7-item Generalized Anxiety Disorder Scale (GAD-7), the 9-item Patient Health Questionnaire (PHQ-9), and the Eysenck Personality Questionnaire, as well as self-reported consumption of psychotropic medication.Results One standard deviation (SD) unit increase in years of education was associated with a lower symptom score of anxiety (−0.20 SD [95%CI: −0.26, −0.14]), depression (−0.11 SD [−0.43, 0.22]), neuroticism (−0.30 SD [−0.53, −0.06]), and lower odds of psychotropic medication consumption (OR: 0.60 [0.52, 0.69]). Estimates from the within-sibship MR analyses showed some attenuation, which however were suggestive of a causal association (anxiety: −0.17 SD [−0.33, −0.00]; depression: −0.18 SD [-1.26, 0.89]; neuroticism: −0.29 SD [−0.43, −0.15]); psychotropic medication consumption: OR, 0.52 [0.34, 0.82]).Conclusions and Relevance Associations between EA and MHC in adulthood, although to some extend explained by dynastic effects and demographic factors, overall remain robust, indicative of a causal effect. However, larger studies are warranted to improve statistical power and further validate our conclusions.Question Are the protective effects of higher educational attainment on the risk of suffering mental health conditions independent from familial (i.e.,dynastic effects) and demographic factors (i.e., assortative mating and population structure)?Findings Although to some extend explained by familial and demographic factors, overall the protective effects of higher educational attainment remain robust.Meaning Our findings are consistent with those of previous observational studies, which suggests that higher educational attainment may causally reduce the risk of suffering a mental health condition.Competing Interest StatementOEN reports having received funding from the Norwegian University of Science and Technology for a review assignment. GDS reports a Scientific Advisory Board Membership for Relation Therapeutics and Insitro. MFVV, LB, PRJ, MT, NMD and BMB declare no conflict of interest to disclose.Funding StatementThe K. G. Jebsen Center for Genetic Epidemiology is financed by Stiftelsen Kristian Gerhard Jebsen and the Faculty of Medicine and Health Sciences, NTNU, Norway. MFVV, PRJ and OEN are funded by The Research Council of Norway, Project Inequalities in non-communicable diseases: Indirect selection or social causation (INDI-INEQ #287347). BMB is funded by the Research Council of Norway (FRIMEDBIO #287347). LB and BMB are supported by grants from the Liaison Committee for Education, Research and Innovation in Central Norway and the Joint Research Committee between St Olavs Hospital and the Faculty of Medicine and Health Sciences, NTNU. GDS works at the Medical Research Council (MRC) Integrative Epidemiology Unit at the University of Bristol, which is supported by MRC (MC_UU_00011/1). NMD is supported by The Research Council of Norway (#295989) and NIMH (MH130448).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was approved by the Regional Committees for Medical Research Ethics South East (REK 2017/2479) and Mid-Norway (REK 2015/1197). All participants signed informed consent for participation and the use of data in research. UK Biobank obtained ethics approval from the North West Multi-centre Research Ethics Committee and obtained informed consent from all study participants.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesResearchers associated with Norwegian research institutes can apply for the use of HUNT material: data and samples - given approval by a Regional Committee for Medical and Health Research Ethics. Researchers from other countries can also apply in cooperation with a Norwegian Principle Investigator. Information for data access can be found at https://www.ntnu.edu/hunt/data. UK Biobank individual-level participant data are available via enquiry to access{at}ukbiobank.ac.uk. All GWAS summary statistics used in the present manuscript are publicly available and can be download from https://gwas.mrcieu.ac.uk/ and https://thessgac.com/papers/.